Cargando…

Are Anticapsular Antibodies the Primary Mechanism of Protection against Invasive Pneumococcal Disease?

BACKGROUND: Antibody to capsular polysaccharide has been the basis of several vaccines that offer protection against invasive disease from Streptococcus pneumoniae. The success of such vaccines has led to the inference that natural protection against invasive pneumococcal disease is largely conferre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lipsitch, Marc, Whitney, Cynthia G, Zell, Elizabeth, Kaijalainen, Tarja, Dagan, Ron, Malley, Richard
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545206/ https://www.ncbi.nlm.nih.gov/pubmed/15696204 http://dx.doi.org/10.1371/journal.pmed.0020015

Ejemplares similares

Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection
por: Diago-Navarro, Elizabeth, et al.
Publicado: (2018)

Anticapsular and Antifungal Activity of α-Cyperone
por: Horn, Connor, et al.
Publicado: (2021)

Erratum for Diago-Navarro et al., “Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection”
por: Diago-Navarro, Elizabeth, et al.
Publicado: (2018)

Effect of Maternally Derived Anti-protein and Anticapsular IgG Antibodies on the Rate of Acquisition of Nasopharyngeal Carriage of Pneumococcus in Newborns
por: Ojal, John, et al.
Publicado: (2018)

Diet as a Risk Factor for Pneumococcal Carriage and Otitis Media: A Cross-Sectional Study among Children in Day Care Centers
por: Tapiainen, Terhi, et al.
Publicado: (2014)

Flavin Reductase Contributes to Pneumococcal Virulence by Protecting from Oxidative Stress and Mediating Adhesion and Elicits Protection Against Pneumococcal Challenge
por: Morozov, Giora I., et al.
Publicado: (2018)

Seasonal Patterns of Invasive Pneumococcal Disease
por: Dowell, Scott F., et al.
Publicado: (2003)

Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination
por: Campo, Joseph J, et al.
Publicado: (2018)

Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children
por: Weinberger, Daniel M, et al.
Publicado: (2019)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Effect of Serotype on Pneumococcal Competition in a Mouse Colonization Model
por: Trzciński, Krzysztof, et al.
Publicado: (2015)

Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence
por: Weinberger, Daniel M., et al.
Publicado: (2009)

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in HIV-Infected and -Uninfected Children in South Africa: A Matched Case-Control Study
por: Cohen, Cheryl, et al.
Publicado: (2014)

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland
por: Vesikari, Timo, et al.
Publicado: (2016)

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
por: Pilishvili, Tamara, et al.
Publicado: (2018)

Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection
por: Huang, Jiachen, et al.
Publicado: (2021)

Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies
por: Gingerich, Aaron D., et al.
Publicado: (2022)

Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination
por: Masala, G. L., et al.
Publicado: (2017)

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study
por: Chan, Jocelyn, et al.
Publicado: (2021)

Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3
por: Porte, Rémi, et al.
Publicado: (2023)

Immunization with Attenuated Pneumococcal Strains Provides Protection against Pneumococcal Colonization in Humans
por: Narciso, Ana Rita, et al.
Publicado: (2023)

Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006–2014
por: Izu, Alane, et al.
Publicado: (2017)

Time from Illness Onset to Death, 1918 Influenza and Pneumococcal Pneumonia
por: Klugman, Keith P., et al.
Publicado: (2009)

Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005–2013
por: Shakoor, Sadia, et al.
Publicado: (2014)

Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage
por: Mitsi, E, et al.
Publicado: (2016)

Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion
por: Jang, A-Yeung, et al.
Publicado: (2019)

Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
por: Conklin, Laura, et al.
Publicado: (2014)

Regionally Compartmentalized Resident Memory T Cells Mediate Naturally Acquired Protection Against Pneumococcal Pneumonia
por: Smith, N.M.S., et al.
Publicado: (2017)

Dynamics of invasive pneumococcal disease in infants < 2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019
por: Ben-Shimol, Shalom, et al.
Publicado: (2023)

Herd immunity alters the conditions for performing dose schedule comparisons: an individual-based model of pneumococcal carriage
por: Yang, Alan, et al.
Publicado: (2019)

Antibodies and Protection Against Invasive Salmonella Disease
por: MacLennan, Calman A.
Publicado: (2014)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
por: Almendares, Olivia M, et al.
Publicado: (2018)

Impact of IgM Antibodies on Cross-Protection against Pneumococcal Serogroups 6 and 19 after Immunization with 7-Valent Pneumococcal Conjugate Vaccine in Children
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

Type I Interferon Protects against Pneumococcal Invasive Disease by Inhibiting Bacterial Transmigration across the Lung
por: LeMessurier, Kim S., et al.
Publicado: (2013)

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
por: Lu, Ying-Jie, et al.
Publicado: (2008)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
por: Feikin, Daniel R., et al.
Publicado: (2013)

Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease
por: Littorin, Nils, et al.
Publicado: (2018)

2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
por: Lewis, Ned, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k1e8o417fsv1trcm8h5olo2n0r